EQUASHIELD® is a privately held medical device company based in Port Washington, New York, founded in 2009. The company specializes in providing a state-of-the-art Closed System Transfer Device (CSTD) for the safe handling of hazardous drugs. With a commitment to safety and ease-of-use, Equashield offers a family of products designed to protect healthcare workers from exposure to hazardous drugs and vapors. Their product portfolio includes closed syringes, adapters, and connectors for pharmacy and nursing applications.
Equashield's products are FDA cleared and CE approved, meeting stringent regulatory requirements under their ISO 13485 quality system management. The company operates a production facility equipped with class 100,000 (ISO-8) clean rooms, ensuring compliance with U.S. Good Manufacturing Practices. Equashield provides extensive in-house service and local support, fostering an environment where medical professionals can confidently serve others without compromising their own health and safety.
By designing and producing innovative protection products, Equashield is creating a safer workplace for healthcare professionals, extending from the compounding in pharmacy to the administration in nursing.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
| Funding Private Equity |
B2B professionals should contact Equashield for its innovative CSTD technology that ensures the safety of healthcare workers. The company's FDA cleared and CE approved products offer a reliable solution for handling hazardous drugs, making them an ideal partner for healthcare facilities seeking to enhance safety protocols.
Sales teams selling medical device solutions, healthcare facility administrators, and safety compliance officers should reach out to Equashield. The company's products are particularly beneficial for those looking to improve safety protocols in pharmacy and nursing environments.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with EQUASHIELD®